Female Urology

Latest News

FDA approves cefepime/enmetazobactam for complicated UTI
FDA approves cefepime/enmetazobactam for complicated UTI

February 27th 2024

The FDA approval is supported by data from the phase 3 ALLIUM trial, which demonstrated the non-inferiority and superiority of cefepime/enmetazobactam vs piperacillin/tazobactam.

Information and Guidance on the Adoption of Surgical Innovation and Technology in Urogynecology
Information and Guidance on the Adoption of Surgical Innovation and Technology in Urogynecology

February 24th 2024

White FDA lettering on blue background
FDA requests additional data regarding cefepime-taniborbactam for cUTI

February 23rd 2024

AUGS Position Statement on Gender Affirmation
AUGS Position Statement on Gender Affirmation

February 22nd 2024

Published data show superiority of cefepime–taniborbactam over meropenem for cUTI
Published data show superiority of cefepime–taniborbactam over meropenem for cUTI

February 20th 2024

Video Interviews
Podcasts

More News

© 2024 MJH Life Sciences

All rights reserved.